Search

Arvinas Inc

Fermé

SecteurSoins de santé

8.27 0.49

Résumé

Variation du prix de l'action

24h

Actuel

Min

7.92

Max

8.38

Chiffres clés

By Trading Economics

Revenu

9.8M

-58M

Ventes

6.1M

16M

BPA

-0.9

Marge bénéficiaire

-369.231

Employés

246

EBITDA

9.6M

-56M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+82.47% upside

Dividendes

By Acuity

Prochains Résultats

5 août 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-101M

523M

Ouverture précédente

7.78

Clôture précédente

8.27

Sentiment de l'Actualité

By Acuity

50%

50%

172 / 342 Classement par Healthcare

Arvinas Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

15 juil. 2026, 23:52 UTC

Correlated Moves
Social Media
News

Western Digital shares fell after hours, closing at about $513.97. Option traders showed bearish sentiment, with puts outpacing calls in volume.

15 juil. 2026, 23:26 UTC

News

Synopsys shares are higher in after-market hours following a Buy rating from analyst Gary Mobley, who set a price target of $570.

15 juil. 2026, 23:16 UTC

Social Media
News

PayPal Holdings Inc. shares are lower in after-market trading amid uncertainty over a $53 billion acquisition offer from Stripe and Advent International.

15 juil. 2026, 23:11 UTC

Correlated Moves
News

The CHF/HKD exchange rate is trading higher, influenced by a decline in the US Producer Price Index and a stronger NY Empire State Manufacturing Index.

15 juil. 2026, 23:06 UTC

Social Media
News

Wedbush initiates coverage on eBay with an Outperform rating. Shares are higher in after-hours trading following positive sentiment and acquisition news.

15 juil. 2026, 23:06 UTC

News

American Airlines Group shares are lower in after-market hours following the appointment of John W. Dietrich to its board amid rising fuel price concerns.

15 juil. 2026, 23:06 UTC

News

Vanguard Total Bond Market ETF is slightly higher in after-market hours, reflecting cautious investor sentiment amid escalating Middle East tensions and oil supply concerns.

15 juil. 2026, 23:02 UTC

News
Social Media
Event

United Airlines Holdings shares fell in after-hours trading despite reporting strong second-quarter earnings of $1.99 per share and revenue of $17.67 billion.

15 juil. 2026, 23:01 UTC

Social Media
News

J.B. Hunt Transport Services shares rose in after-market trading following strong second-quarter results, with revenues up 19% to $3.50 billion and EPS of $1.91.

15 juil. 2026, 23:01 UTC

News

Wedbush initiated coverage on Booking Holdings with an Outperform rating. Shares are higher in after-market trading following a close at $174.85.

15 juil. 2026, 22:16 UTC

News

Micron Technology will participate in the KeyBanc Capital Markets Technology Leadership Forum on August 10, 2026. Shares are higher in after-hours trading.

15 juil. 2026, 20:14 UTC

ETF Constituents
News
Correlated Moves

The Vanguard Large-Cap ETF is lower in after-market hours, influenced by slight declines in major holdings like Microsoft and Apple amid mixed U.S. equity performance.

15 juil. 2026, 20:07 UTC

News

Bitcoin's price is declining amid broader market sentiment shifts following softer inflation readings. Geopolitical tensions may also be influencing the cryptocurrency market.

15 juil. 2026, 20:07 UTC

News
Correlated Moves

Microchip Technology shares are lower today, following a broader Nasdaq decline. Ongoing U.S.-Iran tensions continue to affect overall investor sentiment.

15 juil. 2026, 20:07 UTC

News

Ethereum is trading higher, continuing an upward trend since Tuesday. The U.S. Producer Price Index decline has eased inflation concerns and boosted market sentiment.

15 juil. 2026, 20:07 UTC

News

Bitcoin's price is lower today, influenced by softer inflation data and ongoing geopolitical tensions, despite earlier gains above Tuesday's close.

15 juil. 2026, 20:06 UTC

News

Charter Communications shares rose following Liberty Broadband's $17.65 million insider sale of 129,907 shares, despite a recent revenue decline.

15 juil. 2026, 20:03 UTC

Social Media
News

Amazon.com Inc is higher today, driven by a partnership with Herotel for satellite internet services and leadership changes within Amazon Web Services.

15 juil. 2026, 20:02 UTC

Social Media
News
Macro Event

CSX shares are lower as Benchmark cuts its price target to $4 from $48, while Citizens initiates coverage with a Market Perform rating.

15 juil. 2026, 20:02 UTC

News

Cisco Systems Inc shares are lower, hitting a nine-week low of 111.29 USD amid a broader decline in the Communications Equipment sub-sector.

15 juil. 2026, 20:02 UTC

News

Workday Inc. shares are higher, supported by positive sentiment after a drop in the U.S. Producer Price Index, easing inflation concerns and interest rate hike expectations.

15 juil. 2026, 20:02 UTC

Social Media
News

Apple Inc. shares rose after regulatory approval for its generative AI service in China and Citibank's price target increase to $365 amid market challenges.

15 juil. 2026, 20:02 UTC

Correlated Moves
News
Macro Event
Social Media

Lam Research shares are lower as the Semiconductor Materials & Equipment sector declines. UBS raised its price target to $435, despite negative sentiment from insider selling.

15 juil. 2026, 20:02 UTC

Social Media
Macro Event
Event
News

Cintas Corp's stock rises following strong fiscal fourth-quarter results, with revenue of $2.91 billion and GAAP EPS of $1.26 exceeding analyst expectations.

15 juil. 2026, 20:02 UTC

Correlated Moves
Social Media
Macro Event
News

Applied Materials Inc shares are lower today amid mixed assessments, despite UBS raising its price target to $705. The stock's recent surge raises investor caution.

15 juil. 2026, 19:56 UTC

News
Social Media

Broadcom faces EU scrutiny over VMware practices, yet shares are higher amid positive sentiment for hardware makers and AI demand.

15 juil. 2026, 19:56 UTC

News
Social Media

MercadoLibre shares are lower as Bronstein, Gewirtz & Grossman, LLC announces an investigation into potential claims following extended loan term disclosures.

15 juil. 2026, 19:56 UTC

News

Electronic Arts is rising amid reports of increased confidence in regulatory approval for its $55 billion acquisition at $210 per share.

15 juil. 2026, 19:53 UTC

News
Social Media
Macro Event

Microsoft shares are higher today as Evercore ISI raised its price target to $525. Analysts remain optimistic ahead of the upcoming earnings report.

15 juil. 2026, 19:52 UTC

News
Social Media

Alphabet Inc shares are higher, boosted by Warren Buffett's endorsement and plans for third-party stores in its App Store. Anticipation for earnings also supports momentum.

Comparaison

Variation de prix

Arvinas Inc prévision

Objectif de Prix

By TipRanks

82.47% hausse

Prévisions sur 12 Mois

Moyen 15.09 USD  82.47%

Haut 24 USD

Bas 6 USD

Basé sur 12 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

12 ratings

7

Achat

4

Maintien

1

Vente

Sentiment

By Acuity

172 / 342Classement par Soins de santé

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Arvinas Inc

Arvinas, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. The company engineers proteolysis targeting chimeras (PROTAC) targeted protein degraders that are designed to harness the body's own natural protein disposal system to degrade and remove disease-causing proteins. Its product pipeline includes Bavdegalutamide and ARV-766, investigational orally bioavailable PROTAC protein degraders for the treatment of men with metastatic castration-resistant prostate cancer, which are in Phase 1/2 clinical trials; and ARV-471, an orally bioavailable estrogen receptor degrading PROTAC targeted protein degrader for the treatment of patients with locally advanced or metastatic estrogen receptor+/human epidermal growth factor receptor 2-breast cancer, which is Phase 3 clinical trial. Arvinas, Inc. has collaborations with Pfizer Inc., Genentech, Inc., F. Hoffman-La Roche Ltd., Carrick Therapeutics Limited, and Bayer AG. The company was founded in 2013 and is based in New Haven, Connecticut.
help-icon Live chat